Author: Spannenberg, V.F.
Paper Title Page
MOB02 Progress With a New Radioisotope Production Facility and Construction of Radioactive Beam Facility at iThemba LABS 17
  • J.L. Conradie, J.K. Abraham, H. Anderson, L.S. Anthony, F. Azaiez, S. Baard, R.A. Bark, A.H. Barnard, P. Beukes, J.I. Broodryk, B. Cornelius, J.C. Cornell, J.G. De Villiers, H. Du Plessis, W. Duckitt, D.T. Fourie, M.E. Hogan, I.H. Kohler, C. Lussi, J. Mira, H.W. Mostert, C. Naidoo, F. Nemulodi, M. Sakieldien, V.F. Spannenberg, G.F. Steyn, N. Stodart, I.L. Strydom, R.W. Thomae, M.J. Van Niekerk, P.A. van Schalkwyk
    iThemba LABS, Somerset West, South Africa
  With the termination of the neutron and proton therapy programs at iThemba LABS, the use of the Separated Sector Cyclotron (SSC) has now shifted to nuclear physics research with both stable and radioactive ion beams, as well as biomedical research. A dedicated isotope production facility with a commercial 70 MeV H-minus cyclotron has been approved and both the cyclotron and isotope production target stations will be housed in the vaults that were previously used for the therapy programs. The status of this new facility will be reported. In the future the SSC will mostly be used for nuclear physics research, as well as the production of isotopes that cannot be produced with the 70 MeV H-minus cyclotron. At present the production of the alpha-emitting radionuclide Astatine (211At) with a 28 MeV alpha beam is being investigated. Progress with the construction of a facility for production of radioactive beams will be discussed. There will also be reports on development work on the ECR ion sources and progress with implementation of an EPICS control system.  
slides icon Slides MOB02 [10.580 MB]  
DOI • reference for this paper ※  
About • paper received ※ 13 August 2019       paper accepted ※ 24 September 2019       issue date ※ 20 June 2020  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)